BIOLOGICAL TESTING FACILITY - DMAU
BIOLOGICAL TESTING FACILITY - DMAU
批准号:
10787964
负责人:
DEBRA BURNIN
金额:
$0.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-29 至 2015-09-28
关键词:
AnimalsBiologicalBiological AssayBiological TestingCastor OilClinicalClinical TrialsContraceptive AgentsContraceptive methodsContractorDevelopmentDevicesDosage FormsDoseDrug FormulationsEndocrineEquipmentEvaluationFertilityFormulationFundingGood Manufacturing ProcessGovernmentGovernment AgenciesHumanHuman ResourcesIn VitroInvestigationNational Institute of Child Health and Human DevelopmentPharmaceutical PreparationsPlacebosPowder dose formPreparationProceduresQualifyingQuality ControlRegulationReproductive HealthRouteServicesShippingSupport ContractsSystemTestingValidationWorkanalytical methoddata managementdesignhuman subjectimprovedin vivomanufacturenovel therapeuticssafety testingstability testinguptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Independently and not as an agent of the Government, the Contractor shall furnish all necessary services, qualified personnel, material, equipment and facilities not otherwise provided by the Government as needed to maintain and operate a Biological Testing Facility (BTF) in support of the Contraception and Reproductive Health Branch (CRHB) of the National Institute of Child Health and Human Development. The BTF supported by this contract shall provide the facilities and personnel to perform a wide range of screens, assays, safety tests and analytical procedures, in vivo, in vitro, and ex vivo, for the evaluation of new drugs, formulations and delivery systems relevant to endocrine and anti-fertility activity of compounds that are provided by the Government, and management of the data obtained.
Biological Testing Facility - Dimethandrolone Undecanoate (DMAU) contraceptive and further Manufacture, Formulation, Stability and Testing.
Biological Testing Facility is designed to permit rapid evaluation of new compositions of matter, drug formulations, delivery systems, and devices for anti-fertility or contraceptive and endocrine activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PK/PD, METABOLIC, AND PRECLINICAL STUDIES - SRI INTERNATIONAL
-
批准号:10833878
-
项目类别:
-
资助金额:$208.5万
-
财政年份:2023
-
负责人:DEBRA BURNIN
-
依托单位:
BIOLOGICAL TESTING FACILITY (BTF): TASK ORDER 12- "FORMULATION AND PHARMACEUTICAL CHARACTERIZATION OF MULTIPURPOSE PREVENTION CONTRACEPTION PREVENTION
-
批准号:10706872
-
项目类别:
-
资助金额:$5.35万
-
财政年份:2022
-
负责人:DEBRA BURNIN
-
依托单位:
BIOLOGICAL TESTING FACILITY (BTF) - NONCLINICAL MALE CONTRACEPTIVE DEVELOPMENT SERVICES
-
批准号:10705348
-
项目类别:
-
资助金额:$35.26万
-
财政年份:2022
-
负责人:DEBRA BURNIN
-
依托单位:
BIOLOGICAL TESTING FACILITY – IN VITRO METABOLIC AND IN VIVO PRECLINICAL STUDIES
-
批准号:10705350
-
项目类别:
-
资助金额:$60.49万
-
财政年份:2022
-
负责人:DEBRA BURNIN
-
依托单位:
BIOLOGICAL TESTING FACILITY (BTF) - FORMULATION AND PHARMACEUTICAL CHARACTERIZATION OF MULTIPURPOSE PREVENTION CONTRACEPTION PREVENTION
-
批准号:10932080
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2022
-
负责人:DEBRA BURNIN
-
依托单位:
BIOLOGICAL TESTING FACILITY - STABILITY TESTING, CLINICAL FORMULATION DEVELOPMENT AND MANUFACTURING ACTIVITIES OF CONTRACEPTIVE AGENTS
-
批准号:10618518
-
项目类别:
-
资助金额:$119.95万
-
财政年份:2020
-
负责人:DEBRA BURNIN
-
依托单位:
BIOLOGICAL TESTING FACILITY (BTF) - NONCLINICAL FEMALE CONTRACEPTIVE DEVELOPMENT SERVICES
-
批准号:10710081
-
项目类别:
-
资助金额:$110.0万
-
财政年份:2020
-
负责人:DEBRA BURNIN
-
依托单位:
海外基金